A 55-year-old woman is evaluated in the hospital on postoperative day 6 following an abdom… — USMLE Step 3

A $55$ -year-old woman is evaluated in the hospital on postoperative day $6$ following an abdominal hysterectomy. She was admitted to the general medical ward and started on an intravenous unfractionated heparin infusion $5$ days ago for a right lower extremity deep vein thrombosis. Today, she reports new pain and swelling at the site of a peripheral intravenous catheter in her left arm. Her temperature is $37.2^\circ \text{C}$ ( $99.0^\circ \text{F}$ ), blood pressure is $128/82$ mmHg, and pulse is $88$ /min. Physical examination shows induration, erythema, and tenderness along the left cephalic vein, consistent with superficial thrombophlebitis. There is no active bleeding, and no petechiae are noted.

Laboratory results are as follows:
- Hemoglobin: $12.2$ g/dL
- Platelet count: $110,000/\text{mm}^3$ (Baseline $5$ days ago: $320,000/\text{mm}^3$ )
- Partial thromboplastin time (PTT): $68$ seconds

Which of the following is the most appropriate next step in management?

A
Obtain bilateral upper and lower extremity venous Doppler ultrasonography
B
Discontinue unfractionated heparin and transfuse pooled platelets
Discontinue unfractionated heparin and initiate argatrobanAnswer
D
Discontinue unfractionated heparin and initiate warfarin
E
Continue unfractionated heparin and order a serotonin release assay

Answer

Discontinue unfractionated heparin and initiate argatroban

The correct action is to discontinue unfractionated heparin and initiate a non-heparin anticoagulant such as argatroban. This patient presents with a classic picture of Type 2 Heparin-Induced Thrombocytopenia (HIT). HIT is an immune-mediated prothrombotic disorder caused by antibodies to platelet factor 4 (PF4) complexed with heparin. Diagnosis requires a high index of clinical suspicion, typically evaluated using the 4T score: Thrombocytopenia (drop

>50\%

), Timing (onset

5-10

days after heparin exposure), Thrombosis (new or progressive), and absence of oTher clear causes. This patient has a severe platelet drop (

65\%

decrease), timing of

5

days, and a new thrombosis (superficial thrombophlebitis), giving her a high probability score. When HIT is strongly suspected, the absolute priority is to immediately stop all heparin products and initiate therapeutic-dose anticoagulation with a non-heparin agent (e.g., argatroban, bivalirudin, or fondaparinux) while awaiting confirmatory testing (PF4 ELISA or serotonin release assay).

Step-by-Step Solution

Calculate the 4T score to estimate the clinical probability of Heparin-Induced Thrombocytopenia (HIT).

The patient scores

2

points for thrombocytopenia (

>50\%

drop),

2

points for timing (day

5

), and

2

points for a new thrombosis (superficial thrombophlebitis), yielding a high-probability score of

6

>50\%

drop in platelets occurring

5-10

days after heparin initiation, especially with new thrombosis, is the hallmark presentation of HIT.

Evaluate the current treatment regimen based on the clinical diagnosis.

The current unfractionated heparin infusion is actively causing the immune-mediated platelet destruction and hypercoagulable state.

Continuing heparin or delaying its cessation will lead to potentially fatal arterial or venous thromboses.

Select the appropriate therapeutic intervention.

Immediate cessation of unfractionated heparin and initiation of a direct thrombin inhibitor (e.g., argatroban) or fondaparinux.

A non-heparin anticoagulant must be started immediately to manage the severe prothrombotic state while awaiting confirmatory laboratory testing.

Key Concept

Monitoring for and managing Heparin-Induced Thrombocytopenia (HIT)

Question

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Topics

More questions from this topic